U.S. Professional Services Stock News

If you are wondering whether Surgery Partners is a quietly mispriced opportunity or a value trap in the making, you are not alone. That is exactly what we are going to unpack here. The stock is down 4.9% over the last week and 22.4% year to date, but a 5.0% gain over the past month hints that sentiment may be starting to shift after a long 5 year slide of 42.3%. Recent headlines have focused on Surgery Partners expanding its network of ambulatory surgery centers and deepening relationships...

Earlier this month, Deere & Company expanded its Board from 10 to 11 directors by appointing Cargill Chair and CEO Brian Sikes as an independent director and committee member, while also announcing the upcoming retirement of President, John Deere Financial and CIO Raj Kalathur in January 2026 and affirming a quarterly dividend of US$1.62 per share payable in February 2026. At the same time, President Donald Trump’s public pressure on farm‑equipment pricing and plans to ease environmental...

Earlier this month, Xsolla announced a collaboration with HP to link HP’s Gaming Garage learning platform with Xsolla’s Accelerator, aiming to support over 100,000 aspiring game developers globally through integrated education, incubation, and studio launch pathways. This initiative highlights how HP is using its gaming and education platforms to build long-term engagement with future creators, even as analysts focus on the pressures rising memory costs may place on its core PC business. Now...

If you are wondering whether Unity Software is still a bargain after its big rebound, or if the easy money has already been made, this breakdown will help you think through whether the current price really makes sense. The stock has climbed 9.8% over the last week, 13.6% over the past month, and is now up 99.8% year to date. However, the 5 year return of -66.6% is a reminder of how quickly market sentiment around Unity can swing. Recent price action has come alongside ongoing investor...

Wondering if Globant is a beaten down tech name or a quiet value opportunity waiting to be rediscovered? This breakdown will help you decide whether the current price really makes sense. Despite a modest 7.9% rise over the last month, the stock is still down 67.7% year to date and 68.7% over the past year, which indicates that sentiment has been heavily reset even as some investors are starting to edge back in. Recent news has focused on Globant doubling down on digital transformation, AI...

Helios Technologies has announced that Billy Aldridge will become President of its Electronics Segment on January 4, 2026, after serving as Senior Vice President, Managing Director of the segment since March 31, 2025, and building a career across Enovation Controls, FW Murphy, and Brunswick’s MerCruiser/Mercury division. This appointment elevates a leader with deep electronics and OEM experience at a time when Helios is emphasizing customer engagement and growth in its Electronics...

Beam Therapeutics has released updated Phase 1/2 BEACON trial data for its investigational sickle cell therapy risto-cel, showing efficient cell collection, high base-editing levels, and sustained increases in protective hemoglobin F alongside reductions in harmful hemoglobin S in patients with severe vaso-occlusive crises. A key insight is that risto-cel’s manufacturing process appears both efficient and predictable, with most patients needing only a single stem cell collection cycle, which...

If you are wondering whether Amphenol is still a smart buy after its huge run, or if you are late to the party, this breakdown will help you assess whether the current price makes sense. The stock has paused recently, remaining flat over the last week and down about 3.6% over the past month. That follows a climb of roughly 101% year to date and 90.1% over the last year. These gains have been supported by steady demand for Amphenol's connectivity and sensor solutions across data centers,...

Hewlett Packard Enterprise (HPE) just delivered an earnings update that put its AI and networking pivot front and center, combining stronger non GAAP profitability, hefty new AI system orders, and a higher 2026 earnings outlook. See our latest analysis for Hewlett Packard Enterprise. The latest earnings beat and upbeat 2026 guidance have added fuel to a trend that was already positive, with a 17.65% year to date share price return and a powerful 139.37% five year total shareholder return...

Virgin Galactic Holdings has recently launched a capital realignment plan, repurchasing and retiring about US$355 million of convertible notes, issuing roughly US$46 million of new common stock and pre-funded warrants, and placing about US$203 million of new first lien notes due 2028 to trim debt and reshape its balance sheet. This complex mix of debt reduction, new secured borrowing, and fresh equity raises highlights how Virgin Galactic is trading near-term dilution and higher secured...

If you are wondering whether CNH Industrial is quietly turning into a value opportunity, or if the lower share price is a warning sign, this article will walk you through what the numbers are really saying. The stock has bounced 3.4% over the last week and 2.0% over the past month, but it is still down 11.5% year to date and 16.8% over the last year, which is exactly the kind of setup value investors like to investigate. Recently, the market has been reacting to shifting expectations around...

Best Buy has added Dylan Jadeja, chief executive officer of Riot Games and former Goldman Sachs consumer retail leader, to its Board of Directors, and on December 5, 2025, the company also appointed him to its Compensation and Human Resources Committee and its Finance and Investment Policy Committee effective March 2, 2026. By bringing in a leader with deep experience across gaming, digital content, and finance, Best Buy is signaling a stronger push to align its leadership expertise with...

In recent months, Innovative Industrial Properties has contended with rising tenant defaults that are pressuring funds-from-operations and pushing its dividend payout ratio higher, even as rental revenues show some sequential improvement. This tension between elevated tenant risk and management’s choice to maintain the dividend has sharpened investor focus on whether cash flows can reliably cover future distributions and support re-leasing efforts across the portfolio. We will now examine...

If you have been wondering whether Mosaic is quietly turning into a value play, you are not alone. This article is going to unpack exactly what the market might be missing. The stock is down about 1.5% over the last week, 7.6% over the last month and 8.1% over the past year. It is still up 14.2% over five years, a mixed picture that can hide some interesting value dynamics. Recently, investors have been digesting headlines around fertilizer demand, shifting crop prices and the broader...

Public Storage recently reported an operating update showing that average annual contract rent per square foot for new tenants declined through November 2025, even as it moved to acquire or contract to acquire 88 self-storage facilities for US$949.4 million, adding 6.1 million net rentable square feet this year. The company’s latest investor presentation underlines how this expansion of 2,565 stabilized Same Store Facilities and newly acquired properties could influence future revenue...

Webster Financial Corporation, the parent of Webster Bank, recently lowered its prime lending rate to 6.75% from 7.00%, effective December 11, 2025, affecting borrowing costs for its consumer and commercial customers across its Northeast footprint. This adjustment in Webster’s prime rate offers insight into how management is aligning lending terms with broader interest-rate conditions and client demand, which could influence the mix and growth of its loan portfolio. Next, we’ll examine how...

Toll Brothers recently reported mixed fourth-quarter 2025 results, with revenue rising to US$3,423.4 million while net income slipped to US$446.72 million and earnings per share came in below analyst expectations amid a softer demand backdrop and a 15% decline in backlog. At the same time, the builder is pressing ahead with new luxury communities such as Wilder Ranch in Colorado, Rivercrest in Nevada, and expanded offerings in Washington, underscoring its focus on affluent buyers even as it...

Roche’s upbeat Phase 3 data for its breast cancer SERD giredestrant has lit a fire under Olema Pharmaceuticals (OLMA), with investors recalibrating expectations around the company’s own SERD candidate, palazestrant. See our latest analysis for Olema Pharmaceuticals. The latest pop, including a 15.43% 1 day share price return and a 252.64% 30 day share price return, builds on a powerful backdrop of a 450.81% year to date share price return and a 1152.24% three year total shareholder return...

Advanced Drainage Systems (WMS) is back on investors radar after a recent fund commentary highlighted its better than expected sales and earnings, as well as a reaffirmed fiscal 2026 outlook despite choppy construction markets. See our latest analysis for Advanced Drainage Systems. The latest fund commentary seems to have reminded the market what is working under the hood, with the share price now at $149.6 and a strong year to date share price return of 30.85 percent feeding into a solid 5...

Wondering whether Civitas Resources is a value play or a value trap at today’s price? You are not alone. This stock has quietly shifted from market favorite to contrarian idea. The share price has bounced about 10.5% over the last month but is still down roughly 36.4% year to date and 33.8% over the last year, a mix that often signals either a looming problem or a mispriced opportunity. Recent headlines around Civitas have focused on its portfolio positioning and capital discipline in a...

Travelers Companies (TRV) has been drifting slightly lower over the past week, even after a strong year-to-date run. This naturally raises the question of whether this dip offers a reasonable entry point. See our latest analysis for Travelers Companies. The latest pullback leaves Travelers shares at $278.35, still comfortably ahead for the year thanks to a solid year to date share price return and strong multi year total shareholder returns. This suggests that momentum is cooling rather than...

If you are wondering whether Ultragenyx Pharmaceutical at around $36 a share is a hidden bargain or another biotech value trap, you are in the right place to unpack what the market is really pricing in. The stock is up about 8.3% over the last month but still down sharply over 1 year and 5 years. This pattern suggests sentiment may be shifting even while longer term holders are still deep in the red. Recent attention on Ultragenyx has centered on its rare disease pipeline progress and...

Critical Metals (CRML) just took a big strategic step, executing a 50/50 joint venture term sheet with Romanian state-owned FPCU to build a rare earth processing facility in the European Union without adding debt or equity dilution. See our latest analysis for Critical Metals. The JV news lands after a volatile run, with the 90 day share price return of 44.9 percent and year to date share price return of 37.9 percent contrasting with a softer 22.2 percent one year total shareholder return...

Recent performance sets the stage PTC (PTC) has quietly slipped over the past 3 months, even though its revenue and net income keep growing at mid single digit rates. That gap between fundamentals and share performance is what matters now for investors. See our latest analysis for PTC. The 1 year total shareholder return of negative 12.7 percent, despite a 3 year total shareholder return above 40 percent, suggests momentum has cooled as investors reassess how much they are willing to pay for...